文献速递肝病

MASLD心脏代谢谱的蛋白质组学解析:性别驱动的内型与全身死亡率预测

Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality.
PubMed 文献 · Gut · 2026-07-29

该研究对48 806名UK Biobank参与者(含MRI-PDFF数据)进行潜伏类别分析,识别MASLD临床亚型并揭示性别二态性,通过大规模蛋白质组学构建四蛋白评分PS4,在115 971人扩大队列中验证其全因死亡率预测优于现有非侵入性评分。

要点

  • LCA识别出临床 distinct 的MASLD亚型,疾病严重程度存在显著性别二态性。
  • PS4评分在扩大队列中预测全因死亡率显著优于既定非侵入性评分。
  • PS4蛋白(FABP1、FTCD、ADGRG1、GAST)可解释表型类别对死亡率效应的10-20%。

核心结论

  • MASLD驱动的蛋白质组变化反映连接肝脏代谢功能障碍与长期生存的生物学通路,PS4提供了解析MASLD全身后果的生物学框架。

研究设计与样本

  • 对48 806名具有MRI-PDFF数据的UK Biobank参与者进行潜伏类别分析,随访超过15年。
  • 通过大规模蛋白质组学分析表征预后模式的分子基础,推导四蛋白评分PS4。
  • 在含或不含MRI-PDFF数据的扩大队列(n=115 971)中验证PS4对全因死亡率的预测。
  • 使用中介分析评估PS4蛋白对类别-结局关联的潜在贡献。

主要发现

  • LCA识别出临床 distinct 的MASLD亚型,揭示疾病严重程度的显著性别二态性并识别高风险预后亚组。
  • PS4评分在扩大队列中预测全因死亡率显著优于既定非侵入性评分。
  • PS4组分关联肝脏脂质/一碳代谢(FABP1、FTCD)及免疫/血管完整性(ADGRG1、GAST)通路。
  • PS4蛋白可解释患者表型类别对死亡率估计效应的显著比例(10-20%)。

临床怎么用

  • PS4评分可作为生物学 grounded 的工具,用于识别传统以肝脏为中心评分未捕获的高风险内型。
  • 对MASLD患者进行蛋白质组学分层有助于解析心脏代谢谱的全身性后果并指导预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous condition where overlapping cardiometabolic risk factors challenge accurate prognostic prediction. OBJECTIVES: We aimed to define the molecular heterogeneity underlying MASLD clinical presentation, resolving disease patterns and identifying sub-phenotypes that account for prognostic differences in the general population. DESIGN: We applied latent class analysis (LCA) to 48 806 UK Biobank participants with MRI-based proton density fat fraction (MRI-PDFF) data to define phenotypic subtypes over a >15-year follow-up. Large-scale proteomic profiling characterised the molecular basis of the identified prognostic patterns. This led to the derivation of a four-protein score (PS4), which was robustly validated for all-cause mortality prediction in an expanded cohort with/ without MRI-PDFF data (n=115 971). We used mediation analysis to assess the potential contribution of PS4 proteins to the observed class-outcome associations. RESULTS: The LCA identified clinically distinct MASLD subtypes, revealing pronounced sexual dimorphism in disease severity and identifying high-risk prognostic subgroups. The derived PS4 score significantly outperformed established non-invasive scores in predicting all-cause mortality across the expanded cohort. The PS4 components, linked to hepatic lipid/one-carbon metabolism (FABP1, FTCD) and immune/vascular integrity (ADGRG1, GAST) pathways, were found to account for a significant fraction (10-20%) of the estimated effect of the patient's phenotypic class on mortality outcome. CONCLUSIONS: MASLD-driven proteomic shifts reflect biological pathways that connect hepatic metabolic dysfunction with long-term survival. By resolving the MASLD cardiometabolic spectrum, we identified high-risk endotypes that are not captured by traditional liver-centric scores. The PS4 represents a biologically grounded framework for deciphering the systemic consequences of MASLD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Diambra L, Sookoian S, Pirola CJ, et al. Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality. Gut. 2026. PMID: 42527119. doi:10.1136/gutjnl-2026-338674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。